Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3,4-diaminopyridine for Lambert-Eaton myasthenic syndrome
jRCT1091220208Completed
- Sponsor
- Hiroyuki FUKUDA
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Lambert-Eaton myasthenic syndrome (LEMS) comparing 3,4-diaminopyridine with Placebo (2 arms). Primary endpoint: physical examination. Started Mar 2015; status: completed.
02
Drugs
amifampridine
03
Conditions
Lambert-Eaton myasthenic syndrome (LEMS)
Beyond the preview
Go deeper on jRCT1091220208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220208.